Amiodarone - sanofi-aventis
Alternative Names: Amiodarone IV; AncaronLatest Information Update: 02 Oct 2021
Price :
$50 *
At a glance
- Originator Taisho Pharmaceutical
- Developer Sanofi
- Class Benzofurans; Class III antiarrhythmics; Heart failure therapies; Small molecules
- Mechanism of Action Beta adrenergic receptor antagonists; Calcium channel antagonists; KATP channel inhibitors; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Ventricular arrhythmias